AMA
Pobideł J, Piekarz J, Picheta N, Szklener K. Chemotherapy-induced osteoporosis in pediatric oncology: pathophysiology and treatment. Pediatric Endocrinology Diabetes and Metabolism. 2025;31(4):187-194. doi:10.5114/pedm.2025.158551.
APA
Pobideł, J., Piekarz, J., Picheta, N., & Szklener, K. (2025). Chemotherapy-induced osteoporosis in pediatric oncology: pathophysiology and treatment. Pediatric Endocrinology Diabetes and Metabolism, 31(4), 187-194. https://doi.org/10.5114/pedm.2025.158551
Chicago
Pobideł, Jakub, Julia Piekarz, Natalia Picheta, and Katarzyna Szklener. 2025. "Chemotherapy-induced osteoporosis in pediatric oncology: pathophysiology and treatment". Pediatric Endocrinology Diabetes and Metabolism 31 (4): 187-194. doi:10.5114/pedm.2025.158551.
Harvard
Pobideł, J., Piekarz, J., Picheta, N., and Szklener, K. (2025). Chemotherapy-induced osteoporosis in pediatric oncology: pathophysiology and treatment. Pediatric Endocrinology Diabetes and Metabolism, 31(4), pp.187-194. https://doi.org/10.5114/pedm.2025.158551
MLA
Pobideł, Jakub et al. "Chemotherapy-induced osteoporosis in pediatric oncology: pathophysiology and treatment." Pediatric Endocrinology Diabetes and Metabolism, vol. 31, no. 4, 2025, pp. 187-194. doi:10.5114/pedm.2025.158551.
Vancouver
Pobideł J, Piekarz J, Picheta N, Szklener K. Chemotherapy-induced osteoporosis in pediatric oncology: pathophysiology and treatment. Pediatric Endocrinology Diabetes and Metabolism. 2025;31(4):187-194. doi:10.5114/pedm.2025.158551.
